Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability and Food Effect of Afuresertib in Healthy Volunteers
NCT02040480Phase 1Completed
- Sponsor
- GSK
- Start
- Feb 2014
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of afuresertib in cancer (6 arms), sponsored by GSK. Primary endpoint: Composite of pharmacokinetic parameters at 168 hours. Started Feb 2014; status: completed.
02
Drugs
afuresertib
03
Conditions
cancer
Beyond the preview
Go deeper on NCT02040480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02040480.